Ophthalmology
Moderate to Severe Dry Eye
0
Pipeline Programs↗
2
Active Trials↗
2
Companies Involved↗
Moderate to Severe Dry Eye is an early-stage landscape with 0 programs across 2 companies. The most active players are Ocumension Therapeutics (Shanghai) Co., Ltd, AbbVie.
Intelligence
Pipeline Metrics
Competitive Density
Pipeline Velocity
Mech. Concentration
Completion Rate
Attrition Rate
Competition
Competitive Landscape
Bubble size = clinical trials
Approved
Phase 3
Phase 2
Phase 1
Preclinical
Key Players
Top Companies Companies ranked by the number of pipeline programs they run for this disease.
Pipeline
Programs by Phase
No pipeline programs currently tracked for this disease.
Analysis
Trial Status
9
clinical trials
Completed4 · 44%
Unknown status3 · 33%
Not yet recruiting1 · 11%
Enrolling by invitation1 · 11%
Clinical Trials
Trial Activity
9 trials
Efficacy of 0.28% Sodium Hyaluronate Eye Drops in Patient with Moderate to Severe Dry Eye
Enrolling by invitation·Department of Medical Services Ministry of Public Health of Thailand·Phase 4·NCT06860659·84 enrolled
A Study to Evaluate Safety and Efficacy of rhNGF Eye Solution vs Vehicle in Patients With Moderate to Severe Dry Eye
Completed·—·Phase 2·NCT03982368·261 enrolled
Comparison of Efficacy, Safety and Anti-Inflammatory Effect Between Topical 0.05%Cyclosporine A Emulsion and REFRESH® in Patients With Moderate to Severe Dry Eyes
Unknown status·—·Phase 4·NCT00704275·60 enrolled
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)